Hemostemix Inc.: Corporate Update
(firmenpresse) - CALGARY, ALBERTA -- (Marketwired) -- 01/12/15 -- Hemostemix Inc. (the "Corporation") (TSX VENTURE: HEM) announces Dr. Valentin Fulga, is leaving the company''s management team where he was President, effective immediately. Dr. Fulga will continue to serve as a director.
About Hemostemix
Hemostemix is a public clinical-stage company that develops and commercializes innovative blood-derived cell therapies for medical conditions not adequately addressed by current treatments. Hemostemix Inc. is traded on the TSX Venture Exchange under the trading symbol "HEM".
Neither the TSX Venture Exchange, Inc. nor its Regulation Service Provider (as that term is defined under the policies of the TSX Venture Exchange) has in any way passed upon the merits of this news release and has neither approved nor disapproved of the contents of this press release.
Contacts:
Hemostemix Inc.
Dr. Elmar Burchardt
CEO
(617) 500-8401
Hemostemix Inc.
C.W. (Bill) Baker
Chairman of the Board
(403) 818-7672
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.01.2015 - 08:26 Uhr
Sprache: Deutsch
News-ID 1329458
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
CALGARY, ALBERTA
Phone:
Kategorie:
Healthcare
Anmerkungen:
Diese Pressemitteilung wurde bisher 121 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Hemostemix Inc.: Corporate Update
"
steht unter der journalistisch-redaktionellen Verantwortung von
Hemostemix Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
